Clinical Trial Update: Safety and Efficacy of Cethrin® in Adult Subjects With Acute Cervical Spinal Cord Injury [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Cethrin for acute cervical spinal cord injury has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Spinal Cord Injury

Drugs mentioned

• Cethrin

Snippet

Sponsor: BioAxone BioSciences, Inc. | Conditions: Acute Cervical Spinal Cord Injury | Phase 2 | Status: WITHDRAWN